Company / Assets per Share
United Therapeutics Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$175.77
FY2025
5-year range
$116.14 / $175.77
FY2021-FY2025
Trend
+12.3%
vs FY2024
Sector context
#7 of 210
Health Care
What the data says
Among 210 Health Care companies, United Therapeutics is in the top 3% for assets per share. Assets per Share has increased for 9 consecutive years, from $50.82 in FY2016 to $175.77 in FY2025.
Based on SEC 10-K filings.
175.77 in FY2025 with a 5-year CAGR of +10.8%. Top quartile in the Health Care sector.
Improved from $155.70 to $175.77 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- +9.5%
- 5-Year CAGR
- +10.8%
- 10-Year CAGR
- -
Sector benchmark
Top 3% in Health CareTop 3% of 210This company $175.77 Sector average $353.15
▼
-50.2% below sector average
Key checks
Key Insights
- United Therapeutics's assets per share has grown for 9 consecutive years.
- In FY2025, assets per share increased 12.3% year-over-year.
- Ranks #7 out of 210 companies in the Health Care sector.
- Lowest assets per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 6.00 (safe zone, above 2.9 threshold)
- Strong profit margin: 40.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $175.77 | +12.3% |
| FY2024 | $156.55 | +0.5% |
| FY2023 | $155.70 | +16.2% |
| FY2022 | $134.00 | +15.4% |
| FY2021 | $116.14 | +10.4% |
| FY2020 | $105.16 | +17.1% |
| FY2019 | $89.78 | +14.1% |
| FY2018 | $78.65 | +17.4% |
| FY2017 | $67.02 | +31.9% |
| FY2016 | $50.82 | +9.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026